Financials
- Financial year
- 2025
- Total assets
- €1.2m
- Loss
- -€459,431
- Solvency
- -2.8%
Total assets▲ 9.4%
Net result
20182025
CADSKILLS
ActiveSummary
The computed 12-month bankruptcy probability of CADSKILLS is 6.1% (elevated). The 2025 annual accounts show negative equity (-€31,810) and a net result of -€459,431. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 12% of 270 sector peers (NACE 32, financial year 2025). The company has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Manufacture of medical and dental instruments and supplies
NACE 32500
1 site
Size
€1.2mtotal assets 2025
- Staff
- 7.1 FTE
- Equity
- -€31,810
- Loss
- -€459,431
Turnover not published (abbreviated format)
Structure
- Parent
- ORTHOFACE · 51.78%
- Board
- 4 members
Accounts 22 days early4 of 13 deeds read
Why 33raises riskNegative equity -€31,810Loss of €459,431, the second in a row (financial year 2025)1 change of registered office in 24 monthsSize: 7.1 FTE, total assets €1.2mShow the evidence
Checked score
Score 2025
33
/ 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 10% of its sector peers (NACE 32, micro)
Financial strength · tick = 2024
Weak
Solvency
22-44
equity -2.8% of total assets
Liquidity
17-26
short-term debt 74.8% · cash 5.7%
Profitability
0-30
return on assets -39.8%
Bankruptcy probability, 12 months
6.1%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%lowest value
12-2024: 0.1%● unchanged vs 11-2024
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.3%▲ +0.2 percentage points vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.4%▲ +0.1 percentage points vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025
08-2025: 1.1%▲ +0.7 percentage points vs 07-2025
09-2025: 1.1%● unchanged vs 08-2025
10-2025: 1.1%● unchanged vs 09-2025
11-2025: 1.1%● unchanged vs 10-2025
12-2025: 1.1%● unchanged vs 11-2025
01-2026: 1.1%● unchanged vs 12-2025
02-2026: 1.1%● unchanged vs 01-2026
03-2026: 1.1%● unchanged vs 02-2026
04-2026: 1.2%▲ +0.1 percentage points vs 03-2026
05-2026: 1.4%▲ +0.2 percentage points vs 04-2026
06-2026: 1.3%▼ -0.1 percentage points vs 05-2026
07-2026: 1.3%● unchanged vs 06-2026
08-2026: 6.1%▲ +4.8 percentage points vs 07-2026highest value
09-2026: 6.1%● unchanged vs 08-2026highest value
10-2026: 6.1%● unchanged vs 09-2026highest value
No credit on open account
Liquidity insufficient (current ratio 0.47, compared with 1.25 in 2024, below 1; short-term debt: 74.8% and cash: 5.7% of total assets), and equity is negative.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro): better than 17% on solvency, 14% on liquidity, 6% on profitability and 5% on growth.
The bankruptcy probability was computed on 17-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
raises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€31,810
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
22 days early
2024
28 days early
2023
42 days early
2022
49 days early
2021
47 days early
2020
30 days early
2019
46 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 38 days before the deadline; the sector median (NACE 32) for financial year 2024 is 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
18-10-2026 today31-12-2026 year end31-07-2027 deadline
- Resignations & appointmentsPower of attorney
- Annual accounts filedfinancial year 2025 · abbreviated…
- Resignation: MOMMAERTS Maurice (statutory director)Appointments: AMMANN Marc, ARIGONI Markus…
Key points
- Risk: Negative equityfinancial year 2025: debts exceed assets -€31,810 View
- Caution: Result fell in 2025from -€61,517 to -€459,431 ▼ 647% View
- Caution: Among the weakest 5% on net resultsector median €27,934 · 270 companies -€459,431 View
- Board changedlatest change 05-06-2026 · 4 in office 4 joined · 1 left View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Controlled by ORTHOFACE 51.78% View
- Caution: 2 loss-making years in a rowloss financial year 2025 -€459,431 View
- Flemish supportawarded from 2022 to 2025 €86,260 View
By topic
Board & ownership
- Board
- 4 members
- Parent
- ORTHOFACE · 51.78%
- AMMANN MarcDirector
- ARIGONI MarkusDirector
- BORN SusanneDirector
- SCHMITT Reto RogerDirector
Timeline
- Events
- 27
- Since
- 2007
- Next accounts
- by 31-07-2027
- 31-12-2025Weakest financial year
- 03-07-2025Annual accounts filed
- 12-02-2025Registered office
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Manufacture of medical and dental instruments and suppliesNACE 32500
- Founded
- 09-07-1996
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 15
- Who signs
- Two directors jointly
- Annual meeting
- Second Wednesday of June at 16:00
- Purpose
- “I/ - Het ontwikkelen van medisch inplantmateriaal. Het volgende is een exemplatieve lijst…” (deed in Dutch)
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.